Stem Cell Pathways Contribute to Clinical Chemoresistance in Ovarian Cancer by STEG, Adam D, BEVIS, Kerri S, KATRE, Ashwini A, ZIEBARTH, Angela, DOBBIN, Zachary C, ALVAREZ, Ronald D, KUI ZHANG, CONNER, Michael, LANDEN, Charles N

Get full text

Endoglin (CD105) Contributes to Platinum Resistance and Is A Target for Tumor-Specific Therapy in Epithelial Ovarian Cancer by ZIEBARTH, Angela J, NOWSHEEN, Somaira, YANG, Eddy S, LANDEN, Charles N, STEG, Adam D, SHAH, Monjri M, KATRE, Ashwini A, DOBBIN, Zachary C, HAN, Hee-Dong, LOPEZ-BERESTEIN, Gabriel, SOOD, Anil K, CONNER, Michael

Get full text

Uterine leiomyosarcoma diffusely express disialoganglioside GD2 and bind the therapeutic immunocytokine 14.18-IL2: implications for immunotherapy by Ziebarth, Angela J., Felder, Mildred A., Harter, Josephine, Connor, Joseph P.

Get full text

Completed versus aborted radical hysterectomy for node-positive stage IB cervical cancer in the modern era of chemoradiation therapy by Ziebarth, Angela J, Smith, Haller, Killian, Mary E, Nguyen, Nguyet A, Durst, Jennifer K, Subramaniam, Akila, Kim, Kenneth H, Leath, Charles A, Straughn, J. Michael, Alvarez, Ronald D

Get full text

Smoothened antagonists reverse taxane resistance in ovarian cancer by Steg, Adam D, Katre, Ashwini A, Bevis, Kerri S, Ziebarth, Angela, Dobbin, Zachary C, Shah, Monjri M, Alvarez, Ronald D, Landen, Charles N

Get full text

EDD enhances cell survival and cisplatin resistance and is a therapeutic target for epithelial ovarian cancer by Bradley, Amber, Zheng, Hui, Ziebarth, Angela, Sakati, Wayne, Branham-O’Connor, Melissa, Blumer, Joe B., Liu, Yuying, Kistner-Griffin, Emily, Rodriguez-Aguayo, Cristian, Lopez-Berestein, Gabriel, Sood, Anil K., Landen, Charles N., Eblen, Scott T.

Get full text

Abstract 1728: Targeting hedgehog reverses taxane resistance by Gli-dependent and independent mechanisms in ovarian cancer by Steg, Adam D., Ziebarth, Angela, Katre, Ashwini, Landen, Charles N.

Get full text

Abstract 5475: Endoglin (CD105) is a target for ovarian cancer cell-specific therapy through induction of DNA damage by Ziebarth, Angela J., Nowsheen, Somaria, Steg, Adam D., Shah, Monjri M., Katre, Ashwini A., Dobbin, Zachary C., Sood, Anil K., Conner, Michael G., Yang, Eddy S., Landen, Charles N.

Get full text

Abstract 1649: The E3 ubiquitin ligase EDD regulates platinum resistance and is a novel therapeutic target for epithelial ovarian cancer by Bradley, Amber T., Zheng, Hui, Ziebarth, Angela, Sakati, Wayne, Eier, Sande, Lopez-Berestein, Gabriel, Sood, Anil K., Landen, Charles, Eblen, Scott T.

Get full text

Effects of a proposed quality improvement process in the proportion of the reported ultrasound findings unsupported by stored images by Schenone, Mauro, Ziebarth, Sarah, Duncan, Jose, Stokes, Lea, Hernandez, Angela

Get full text